{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:39:05Z","timestamp":1790217545897,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022LSW002"],"award-info":[{"award-number":["ZR2022LSW002"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024MH228"],"award-info":[{"award-number":["ZR2024MH228"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772281"],"award-info":[{"award-number":["81772281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31371321"],"award-info":[{"award-number":["31371321"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.colsurfb.2025.115284","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:09:59Z","timestamp":1763636999000},"page":"115284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Novel nanoparticle-combined therapy through EGFR and PD-L1 blockade: PFPR-siRNA-mediated suppressing NSCLC proliferation via PDT and enhanced antitumor immunity"],"prefix":"10.1016","volume":"259","author":[{"given":"Meiling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangling","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran-Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8090-2180","authenticated-orcid":false,"given":"Shu-Yang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2025.115284_bib1","article-title":"Nanomedicine combats drug resistance in lung cancer","volume":"36","author":"Zheng","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.colsurfb.2025.115284_bib2","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/cncr.34757","article-title":"Targeted therapy for lung cancer: beyond EGFR and ALK","volume":"129","author":"Herrera-Ju\u00e1rez","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.colsurfb.2025.115284_bib3","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1080\/07391102.2023.2252082","article-title":"An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)","volume":"42","author":"Pal","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.colsurfb.2025.115284_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-025-02285-y","article-title":"NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer","volume":"24","author":"Dai","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115284_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01391-4","article-title":"Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance","volume":"15","author":"Fu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115284_bib6","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.3390\/ijms22126288","article-title":"Anti-PD1\/PD-L1 immunotherapy for non-small cell lung cancer with actionable oncogenic driver mutations","volume":"22","author":"Dantoing","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115284_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.17305\/bb.2023.9265","article-title":"Refining PD-1\/PD-L1 assessment for biomarker-guided immunotherapy: a review","volume":"24","author":"Zdrenka","year":"2024","journal-title":"Biomol. Biomed."},{"key":"10.1016\/j.colsurfb.2025.115284_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142843","article-title":"Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC","volume":"7","author":"Tu","year":"2022","journal-title":"Jci Insight"},{"key":"10.1016\/j.colsurfb.2025.115284_bib9","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.colsurfb.2025.115284_bib10","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3390\/molecules27041391","article-title":"Plant-based synthesis of gold nanoparticles and theranostic applications: a review","volume":"27","author":"Muddapur","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2025.115284_bib11","first-page":"420","article-title":"Evaluation of green synthesized gold nanoparticles from abrus precatorius seeds for their antibacterial, anti-inflammatory, anti-proliferative and antidiabetic properties","volume":"41","author":"Muddapur","year":"2022","journal-title":"Lat. Am. J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115284_bib12","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.3390\/ijms232012420","article-title":"Polydopamine copolymers for stable drug nanoprecipitation","volume":"23","author":"Niezni","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115284_bib13","article-title":"A PDA-functionalized 3D lung scaffold bioplatform to construct complicated breast tumor microenvironment for anticancer drug screening and immunotherapy","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.colsurfb.2025.115284_bib14","first-page":"546","article-title":"PDA-BPs integrated mussel-inspired multifunctional hydrogel coating on PPENK implants for anti-tumor therapy, antibacterial infection and bone regeneration","volume":"27","author":"Li","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.colsurfb.2025.115284_bib15","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.2147\/IJN.S442446","article-title":"IL-12-overexpressed nanoparticles suppress the proliferation of melanoma through inducing ICD and activating DC, CD8+T, and CD4+T cells","volume":"19","author":"Shen","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2025.115284_bib16","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1039\/D1BM01124C","article-title":"Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer","volume":"9","author":"Peng","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.colsurfb.2025.115284_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-024-05854-x","article-title":"m6A-methylated KCTD21-AS1 regulates macrophage phagocytosis through CD47 and cell autophagy through TIPR","volume":"7","author":"Liang","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.colsurfb.2025.115284_bib18","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.3390\/molecules28247989","article-title":"Dimethyl bisphenolate ameliorates carbon tetrachloride-induced liver injury by regulating oxidative stress-related genes","volume":"28","author":"Wang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2025.115284_bib19","doi-asserted-by":"crossref","first-page":"e2528","DOI":"10.1038\/cddis.2016.432","article-title":"Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth","volume":"7","author":"Zhang","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.colsurfb.2025.115284_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1032850","article-title":"WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P\/miR-628\/SMAD3 axis","volume":"12","author":"Wei","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115284_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/pharmaceutics15010015","article-title":"Frontiers in preparations and promising applications of mesoporous polydopamine for cancer diagnosis and treatment","volume":"15","author":"Ma","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.115284_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2025.117997","article-title":"Flower-like ytterbium Prussian blue analogue nanozyme with freeze-drying method for colorimetric\/photothermal\/smartphone triple-mode detection of thiosulfate","volume":"290","author":"Wang","year":"2025","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.colsurfb.2025.115284_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/18715206MTA1uNjQp3","article-title":"A review of chemotherapy and photodynamic therapy for lung cancer treatment","volume":"21","author":"El-Hussein","year":"2021","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.colsurfb.2025.115284_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.colsurfb.2025.115284_bib25","article-title":"Deferoxamine Alleviates Osteoarthritis by Inhibiting Chondrocyte Ferroptosis and Activating the Nrf2 Pathway","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2025.115284_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13158","article-title":"Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1\u03b1\/SLC7A11 pathway","volume":"55","author":"Yuan","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.colsurfb.2025.115284_bib27","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.3390\/ijms23126489","article-title":"EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment","volume":"23","author":"Madeddu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115284_bib28","article-title":"The application of nanoparticles in delivering small RNAs for cancer therapy","volume":"15","author":"Zhou","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115284_bib29","doi-asserted-by":"crossref","first-page":"e008794","DOI":"10.1136\/jitc-2024-008794","article-title":"Preclinical development of novel PD-L1 tracers and first-in-human study of [Ga]Ga-NOTA-RW102 in patients with lung cancers","volume":"12","author":"Zhang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115284_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/imm.13588","article-title":"CD8 T cell exhaustion in anti-tumour immunity: The new insights for cancer immunotherapy","volume":"168","author":"Huang","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.colsurfb.2025.115284_bib31","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","article-title":"A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer","volume":"27","author":"Bassez","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.colsurfb.2025.115284_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13020-025-01148-4","article-title":"The association between acupuncture and response to immune checkpoint inhibitors in non-small cell lung cancer","volume":"20","author":"Zhou","year":"2025","journal-title":"Chin. Med."},{"key":"10.1016\/j.colsurfb.2025.115284_bib33","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.7150\/ijbs.102859","article-title":"Mechanism of ferroptosis and its role in disease development","volume":"21","author":"Ye","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115284_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jconrel.2022.01.034","article-title":"Nanodrug delivery systems for ferroptosis-based cancer therapy","volume":"344","author":"Wang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2025.115284_bib35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.colsurfb.2025.115284_bib36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s12951-022-01663-8","article-title":"Ferroptosis assassinates tumor","volume":"20","author":"Luo","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2025.115284_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01784-0","article-title":"New opportunities for RGD-engineered metal nanoparticles in cancer","volume":"22","author":"Qin","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2025.115284_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122587","article-title":"RGD-decorated PLGA nanoparticles improved effectiveness and safety of cisplatin for lung cancer therapy","volume":"633","author":"Yadav","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2025.115284_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biopha.2018.06.137","article-title":"RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy","volume":"106","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2025.115284_bib40","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"A. Investigators, perioperative durvalumab for resectable non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.colsurfb.2025.115284_bib41","series-title":"Mutated Advanced NSCLC","first-page":"41","article-title":"Overall survival with osimertinib in untreated","author":"Ramalingam","year":"2020"},{"key":"10.1016\/j.colsurfb.2025.115284_bib42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MCP.0000000000000895","article-title":"Pulmonary adverse events following immune checkpoint inhibitors","volume":"28","author":"Spagnolo","year":"2022","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.colsurfb.2025.115284_bib43","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.3390\/ijms20163951","article-title":"Understanding the mechanisms of resistance in -positive NSCLC: from tissue to liquid biopsy to guide treatment strategy","volume":"20","author":"Del Re","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115284_bib44","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2021.5270","article-title":"Mechanisms and management of 3rd-generation EGFR-TKI resistance in advanced non-small cell lung cancer (Review)","volume":"59","author":"He","year":"2021","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.colsurfb.2025.115284_bib45","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/2159-8290.CD-20-1543","article-title":"Resistance to durvalumab and durvalumab plus tremelimumab is associated with functional mutations in patients with non-small cell lung cancer and is reversed by STAT3 knockdown","volume":"11","author":"Pore","year":"2021","journal-title":"Cancer Discov."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652500791X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652500791X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:57:42Z","timestamp":1779105462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092777652500791X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":45,"alternative-id":["S092777652500791X"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115284","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel nanoparticle-combined therapy through EGFR and PD-L1 blockade: PFPR-siRNA-mediated suppressing NSCLC proliferation via PDT and enhanced antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115284"}}